Discontinuation report MENJUGATE LIQUID
| Report ID | 268590 |
| Drug Identification Number | 02440709 |
| Brand name | MENJUGATE LIQUID |
| Common or Proper name | Meningococcal Group C Conjugate Vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN |
| Strength(s) | 10MCG 25MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10s |
| ATC code | J07AH |
| ATC description | BACTERIAL VACCINES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-03-31 |
| Actual discontinuation date | |
| Remaining supply date | 2027-05-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-10-03 | French | Compare |
| v1 | 2025-10-03 | English | Compare |
Showing 1 to 2 of 2